BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 31324898)

  • 21. Narcolepsy: clinical approach to etiology, diagnosis, and treatment.
    Koziorynska EI; Rodriguez AJ
    Rev Neurol Dis; 2011; 8(3-4):e97-106. PubMed ID: 22249574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
    Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
    Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.
    Campos JHC; Aguilar ACR; Antoneli F; Truzzi G; Briones MRS; Ferreira RC; Coelho FMS
    BMC Neurol; 2022 Nov; 22(1):439. PubMed ID: 36401198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of glymphatic function in narcolepsy using DTI-ALPS index.
    Gumeler E; Aygun E; Tezer FI; Saritas EU; Oguz KK
    Sleep Med; 2023 Jan; 101():522-527. PubMed ID: 36535226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Narcolepsy.
    Barateau L; Pizza F; Plazzi G; Dauvilliers Y
    J Sleep Res; 2022 Aug; 31(4):e13631. PubMed ID: 35624073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narcolepsy].
    Colombo PP; Zaccagni M; Ubertini C; Vitali M; Aceti F
    Riv Psichiatr; 2009; 44(1):15-27. PubMed ID: 20066934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation of hypothalamus for narcolepsy-cataplexy in mice.
    Rogers AA; Aiani LM; Blanpain LT; Yuxian S; Moore R; Willie JT
    Brain Stimul; 2020; 13(5):1305-1316. PubMed ID: 32320748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narcolepsy with cataplexy.
    Dauvilliers Y; Arnulf I; Mignot E
    Lancet; 2007 Feb; 369(9560):499-511. PubMed ID: 17292770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects and pathophysiology of narcolepsy.
    Dauvilliers Y; Billiard M; Montplaisir J
    Clin Neurophysiol; 2003 Nov; 114(11):2000-17. PubMed ID: 14580598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Narcolepsy].
    Mayer G
    Nervenarzt; 2014 Jan; 85(1):26, 28-34. PubMed ID: 24408296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circuit mechanisms of sleepiness and cataplexy in narcolepsy.
    Pintwala S; Peever J
    Curr Opin Neurobiol; 2017 Jun; 44():50-58. PubMed ID: 28343142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel method for evaluation of eye movements in patients with narcolepsy.
    Christensen JAE; Kempfner L; Leonthin HL; Hvidtfelt M; Nikolic M; Kornum BR; Jennum P
    Sleep Med; 2017 May; 33():171-180. PubMed ID: 28087252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of hypocretin based therapy in narcolepsy.
    Takenoshita S; Sakai N; Chiba Y; Matsumura M; Yamaguchi M; Nishino S
    Expert Opin Investig Drugs; 2018 Apr; 27(4):389-406. PubMed ID: 29623725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans.
    Nishino S; Riehl J; Hong J; Kwan M; Reid M; Mignot E
    Neurosci Res; 2000 Dec; 38(4):437-46. PubMed ID: 11164570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.